An underground economy for unlicensed weight-loss drugs is propelled by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.
Experimental Treatment Acquiring Popularity Via Social Media
The experimental drug, which remains in research studies, is being promoted by social media influencers for its supposed fat-burning effects. Followers are urged to message these profiles directly for source information, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors market the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Medical Professionals Voice Worries
However, doctors and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals administering products of unknown origin.
Several professionals said the popularity for the experimental drug could be connected to the increasing cost of licensed slimming treatments such as Mounjaro.
Legal Status and Implementation
Marketing the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unapproved medication that must not be marketed or distributed for human use under the British medical regulations.
Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.
Service Response and Material Elimination
Based on TikTok, the service has removed problematic content and banned associated hashtags and search suggestions. The company said it was committed to maintaining the platform secure and investing in enhancing compliance measures.
Online Trading Activities
Investigations also discovered groups with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which operates like a public directory. Entering “retatrutide” immediately brings up groups with thousands of users, populated with images of slimming results, positive reviews and detailed guides for preparing or administering at residence.
Within minutes of joining one community, a seller posted WhatsApp details, where most purchases take place. The seller sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Product Information and Costs
Inside these communities, messages display black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at residence with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how much time a pen should be used, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Safety Measures
A representative for Telegram said it regularly moderated dangerous material on its platform including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are injecting substances they cannot confirm. Even if the research behind this drug is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the surge in demand to current price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are using social media. But fake injections are extremely risky. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she said.
Her team has previously encountered individuals injured by self-injection from unconfirmed sources. “We recognize the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly investigational product not yet authorized … may expose patients to potentially significant medical dangers”.
